Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posttreatment Effects of Naltrexone
NCT00523133Phase 2Completed
- Sponsor
- Indiana University School of Medicine
- Start
- Sep 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of naltrexone in alcohol dependence (4 arms), sponsored by Indiana University School of Medicine. Primary endpoint: Percent Days Abstinent at 18 months. Started Sep 2000; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00523133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00523133.